E-tegra Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms

NCT02485496 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2022-05-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate clinical and technical success as well as safety and feasibility of the E-tegra Stent Graft System used in endovascular treatment of infrarenal aortic aneurysm.

Conditions

  • Abdominal Aortic Aneurysm
  • AAA

Interventions

DEVICE

Endovascular abdominal repair

Sponsors & Collaborators

  • JOTEC GmbH

    lead INDUSTRY

Principal Investigators

  • Sven Seifert, Dr. · Klinikum Chemnitz

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2020-07-31
Completion
2021-12-31

Countries

  • France
  • Germany
  • Poland
  • Spain
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02485496 on ClinicalTrials.gov